Medicine’s Mark Cameron weighs in on FDA’s decision to approve booster doses for 12- to 15-year-olds

FDA approves use of Pfizer vaccine for those between 12 and 15 years old

Consumer Affairs: Mark Cameron, associate professor at the School of Medicine, discussed the FDA’s recent approval of booster doses of Pfizer’s COVID vaccine for children between 12 and 15 years of age.